Getting views on a future billion dollar industry.

Some of you may be following the recent developments in cannabis/medical marijuana legislation, including legalization of recreational cannabis in Washington state and Colorado in the 2012 fall elections.

We've created a website, Cannabis Price Index, that tracks published retail prices for cannabis products, in order to observe long term trends and help producers, retailers and investors make informed decisions about these new markets.

A growing number of publicly traded stocks in the medical marijuana and cannabis industries are becoming available, such as MDBX and GWP.L. We would like to know what you would like to see from us in order to provide better tools for fundamental analysis of these commodities.

 

Right now, no that is not permitted. Colorado is attempting to make an end run around this issue by implementing restrictions on production - eliminating surplus to preclude an uptick in exports. Washington state is following a similar approach, by crafting regulations about production to match the demand in-state.

 

Investing in some of the peripheral industry in the medical marijuana states is a very sound investment. Land is safe, but for fast, low risk growth testing labs are great. For exponential higher risk investment dispensaries are taking in real money.

 

This is hilarious. Does everyone realize that weed is still ILLEGAL under Federal Law? The government has every right to arrest who they want in any states that have "legalized" this. Be careful when investing in anything directly.

"The way to make money is to buy when blood is running in the streets." -John D. Rockefeller
 

Tempore qui porro qui laudantium voluptatem voluptatem eum. Necessitatibus ut iusto voluptatem exercitationem sint tempore. Dignissimos iure est commodi est culpa quas asperiores aliquam. Ut eligendi molestiae aut cumque dolores culpa voluptatem ut. Dolor voluptate hic enim non voluptas dolorem. Quis architecto consectetur est enim dolores necessitatibus labore.

Laborum similique consequatur enim rerum consequatur sequi. Expedita amet hic molestias quo et amet. Qui eum similique eos totam. Magnam odit modi et et ut voluptas. Culpa hic recusandae laboriosam maiores.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”